9881. Nitric oxide-induced downregulation of Cdk2 activity and cyclin A gene transcription in vascular smooth muscle cells.
Nitric oxide (NO) inhibits vascular smooth muscle cell (VSMC) proliferation and neointima formation after balloon injury. However, the molecular mechanisms underlying NO-mediated growth arrest are poorly understood. In the present study, we examined the effects of the NO donors sodium nitroprusside (SNP) and S-nitroso-N-acetylpenicillamine (SNAP) on cell cycle activity in VSMCs.
9882. Arginine vasopressin enhances sympathetic constriction through the V1 vasopressin receptor in human saphenous vein.
作者: P Medina.;A Acuña.;J B Martínez-León.;E Otero.;J M Vila.;M Aldasoro.;S Lluch.
来源: Circulation. 1998年97卷9期865-70页
Arginine vasopressin (AVP) not only acts directly on blood vessels through V1 receptor stimulation but also may modulate adrenergic-mediated responses in animal experiments in vivo and in vitro. The aim of the present study was to investigate whether AVP can contribute to an abnormal adrenergic constrictor response of human saphenous veins.
9883. Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats.
作者: S Janssens.;D Flaherty.;Z Nong.;O Varenne.;N van Pelt.;C Haustermans.;P Zoldhelyi.;R Gerard.;D Collen.
来源: Circulation. 1998年97卷13期1274-81页
Loss of endothelial NO production after arterial injury may contribute to restenosis, characterized by neointima formation and elastic recoil. Adenovirus-mediated transfer of the gene encoding NO synthase (NOS) in balloon-injured arteries may restore NO production and inhibit neointima formation.
9884. Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.
作者: S E Lipshultz.;K A Easley.;E J Orav.;S Kaplan.;T J Starc.;J T Bricker.;W W Lai.;D S Moodie.;K McIntosh.;M D Schluchter.;S D Colan.
来源: Circulation. 1998年97卷13期1246-56页
The frequency of, course of, and factors associated with cardiovascular abnormalities in pediatric HIV are incompletely understood.
9885. Heterogeneous immediate effects of partial left ventriculectomy on cardiac performance.
作者: J Gorcsan.;A M Feldman.;R L Kormos.;W A Mandarino.;A J Demetris.;R J Batista.
来源: Circulation. 1998年97卷9期839-42页
Partial left ventriculectomy (PLV) is a novel surgical treatment for severe heart failure consisting of resection of a large wedge of myocardium to reduce wall stress and restore the normal mass-volume ratio. Although ejection fraction (EF) has been shown to improve after PLV, few other physiological data describing its immediate effects on left ventricular (LV) performance are available.
9886. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.
作者: J B Muhlestein.;J L Anderson.;E H Hammond.;L Zhao.;S Trehan.;E P Schwobe.;J F Carlquist.
来源: Circulation. 1998年97卷7期633-6页
Chlamydia pneumoniae infection has been associated with atherosclerosis by serological studies and detection of bacterial antigen within plaque. We sought to evaluate a possible causal role in an animal model.
9887. Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance.
作者: J S Borer.;C Hochreiter.;E M Herrold.;P Supino.;M Aschermann.;D Wencker.;R B Devereux.;M J Roman.;M Szulc.;P Kligfield.;O W Isom.
来源: Circulation. 1998年97卷6期525-34页
Optimal criteria for valve replacement are unclear in asymptomatic/minimally symptomatic patients with aortic regurgitation (AR) and normal left ventricular (LV) performance at rest. Moreover, previous studies have not assessed the prognostic capacity of load-adjusted LV performance ("contractility") variables, which may be fundamentally related to clinical state. Therefore, 18 years ago, we set out to test prospectively the hypothesis that objective noninvasive measures of LV size and performance and, specifically, of load-adjusted variables, assessed at rest and during exercise (ex), could predict the development of currently accepted indications for operation for AR.
9888. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation.
作者: R Krams.;M J Kofflard.;D J Duncker.;C Von Birgelen.;S Carlier.;M Kliffen.;F J ten Cate.;P W Serruys.
来源: Circulation. 1998年97卷3期230-3页
Ischemia occurs frequently in hypertrophic cardiomyopathy (HCM) without evidence of epicardial stenosis. This study evaluates the hypothesis that the occurrence of ischemia in HCM is related to remodeling of the coronary microcirculation.
9889. Composition of human thrombus assessed by quantitative colorimetric angioscopic analysis.
作者: K G Lehmann.;R J van Suylen.;J Stibbe.;C J Slager.;J A Oomen.;A Maas.;C di Mario.;P deFeyter.;P W Serruys.
来源: Circulation. 1997年96卷9期3030-41页
Angioscopy surpasses other diagnostic tools, such as angiography and intravascular ultrasound, in detecting arterial thrombus. This capability arises in part from the unique ability of angioscopy to assess true color during imaging. In practice, hardware-induced chromatic distortions and the subjectivity of human color perception substantially limit the theoretic potential of angioscopic color. We used a novel application of tristimulus colorimetry to quantify thrombus color to both aid in its detection and assess its composition.
9890. Comparison of immediate and intermediate-term results of intravascular ultrasound versus angiography-guided Palmaz-Schatz stent implantation in matched lesions.
作者: R Albiero.;T Rau.;M Schlüter.;C Di Mario.;B Reimers.;D G Mathey.;J M Tobis.;J Schofer.;A Colombo.
来源: Circulation. 1997年96卷9期2997-3005页
Intravascular ultrasound (IVUS) provides more precise information than angiography about vascular dimensions. This information is used by some centers to optimize intracoronary stent implantation. There are no direct comparisons of the effects on restenosis of optimal IVUS-guided versus angiography-directed high-pressure stenting.
9891. Direct vascular effects of furosemide in humans.
作者: P Pickkers.;T P Dormans.;F G Russel.;A D Hughes.;T Thien.;N Schaper.;P Smits.
来源: Circulation. 1997年96卷6期1847-52页
In humans, hemodynamic changes observed within minutes after systemic administration of furosemide are often referred to as direct vasoactivity. However, these immediate changes do not per se imply a direct vascular effect. We examined the genuine direct vascular effects of furosemide on the human forearm vascular bed and dorsal hand vein.
9892. Functional evaluation of lipid-lowering therapy by pravastatin in the Regression Growth Evaluation Statin Study (REGRESS).
作者: W R Aengevaeren.;G J Uijen.;J W Jukema.;A V Bruschke.;T van der Werf.
来源: Circulation. 1997年96卷2期429-35页
Lipid-lowering therapy during 2 years in the Regression Growth Evaluation Statin Study (REGRESS) was associated with less progression of coronary atherosclerosis in the pravastatin group compared with the placebo group. The effect of lipid-lowering therapy on the functional state of the coronary circulation is less well known. The purpose of this study was to evaluate this effect.
9893. Coronary stenting after rotational atherectomy in calcified and complex lesions. Angiographic and clinical follow-up results.
作者: I Moussa.;C Di Mario.;J Moses.;B Reimers.;L Di Francesco.;G Martini.;J Tobis.;A Colombo.
来源: Circulation. 1997年96卷1期128-36页
Treatment of calcified (in contrast to simple) lesions with PTCA has been associated with a lower success rate and more procedural complications. Rotablation can improve acute results, but the high restenosis rate remains a problem. The purpose of this study was to evaluate the clinical and angiographic outcome of patients with complex and calcified lesions treated with a combination of rotablation and stenting.
9894. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.
作者: G Davì.;P Gresele.;F Violi.;S Basili.;M Catalano.;C Giammarresi.;R Volpato.;G G Nenci.;G Ciabattoni.;C Patrono.
来源: Circulation. 1997年96卷1期69-75页
Previous studies relating increased thromboxane (TX) biosynthesis to cardiovascular risk factors do not answer the question whether platelet activation is merely a consequence of more prevalent atherosclerotic lesions or reflects the influence of metabolic and hemodynamic disturbances on platelet biochemistry and function.
9895. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC).
作者: W Klein.;A Buchwald.;S E Hillis.;S Monrad.;G Sanz.;A G Turpie.;J van der Meer.;E Olaisson.;S Undeland.;K Ludwig.
来源: Circulation. 1997年96卷1期61-8页
Low-molecular-weight heparin has a number of pharmacological and pharmacokinetic advantages over unfractionated heparin that make it potentially suitable, when used in combination with aspirin, for the treatment of unstable coronary artery disease.
9896. Histopathology of in-stent restenosis in patients with peripheral artery disease.
作者: M Kearney.;A Pieczek.;L Haley.;D W Losordo.;V Andres.;R Schainfeld.;K Rosenfield.;J M Isner.
来源: Circulation. 1997年95卷8期1998-2002页
Clinical studies have suggested that smooth muscle cell (SMC) hyperplasia is the most likely cause of in-stent restenosis. However, pathological data regarding this issue are limited. Specifically, direct evidence of proliferative activity in tissues excised from stenotic stents has not been previously reported.
9897. Coronary microcirculation in health and disease. Summary of an NHLBI workshop.
This article summarizes a 2-day workshop on the coronary microcirculation held in Bethesda, Md, in September 1994 and sponsored by the National Heart, Lung, and Blood Institute of the National Institutes of Health. The workshop explored a variety of topics pertaining to coronary microvascular physiology and pathophysiology. The latest methodologies that are being used to investigate the coronary microvasculature, including endoscopic microscopy of the intramural coronary microvasculature and micro-x-ray computerized tomography, were discussed. The most recent advances in the regulation of the coronary microcirculation-for example, myogenic and flow-dependent responses, KATP channels, and regional heterogeneity-were reported. The workshop touched on the relation of the microcirculation to clinically important conditions and offered recommendations for future research in this important area. Comparisons are made to recent advances in the peripheral circulation and current gaps in our knowledge concerning the coronary microcirculation. In recent years, research on the coronary microcirculation has made substantial advances, in part as a result of investigations in the peripheral microcirculation but also because of the application of unique methodologies. This research is providing new ways to investigate abnormalities of myocardial perfusion, an area of inquiry that until recently has been limited to examination of coronary pressure-flow relationships.
9898. Long-term implications of reocclusion on left ventricular size and function after successful thrombolysis for first anterior myocardial infarction.
Successful thrombolysis can prevent left ventricular dilatation after acute myocardial infarction. However, in almost 30% of patients, reocclusion occurs. The aim of this study was to assess the long-term implications of reocclusion on left ventricular size and function.
9899. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction.
作者: W K Lagrand.;H W Niessen.;G J Wolbink.;L H Jaspars.;C A Visser.;F W Verheugt.;C J Meijer.;C E Hack.
来源: Circulation. 1997年95卷1期97-103页
Rises in circulating C-reactive protein (CRP), the prototypical acute-phase protein in humans, correlate with clinical outcome in patients with myocardial ischemia and infarction. We hypothesized that these correlations might reflect active participation of CRP in the local inflammatory response ensuing in the jeopardized myocardium because on binding to a ligand, CRP is able to activate the classic pathway of complement, and in addition, complement activation has been shown to occur locally in infarcted myocardium.
|